# Rituximab Versus Ravulizumab, Inebilizumab, Satralizumab, and Eculizumab in NMOSD

> clinical trial · VERIFIED · 2026-06-24

Status: NOT_YET_RECRUITING · Sponsor: Massachusetts General Hospital · Condition: NMOSD

- Company: Massachusetts General Hospital
- Sector: neurology
- Primary source: https://clinicaltrials.gov/study/NCT07010302

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.